Berrin Erdağ

Berrin Erdağ

Auto-generated profile, based on publicly available information

Berrin Erdağ

Istanbul Aydin Univ, Dept Med Biol, Basic Med Sci, Is Tanbul, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2021 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
MÖMelis Denizci Öncü
Melis Denizci Öncü
BBBertan Koray Balcıoğlu
Bertan Koray Balcıoğlu
BOBeytullah Ozgur
Beytullah Ozgur
HÖHasan Ümit Öztürk
Hasan Ümit Öztürk
MSMüge Serhatlı
Müge Serhatlı
ABAylin Özdemir Bahadır
Aylin Özdemir Bahadır

1 September 2012 in New Biotechnology
Verified
Journal Article
Open access
BEBerrin Erdag
Berrin Erdag
KBKoray Bertan Balcioglu
Koray Bertan Balcioglu
AOAylin Ozdemir-Bahadır
Aylin Ozdemir-Bahadır
DHDuygu Hınç
Duygu Hınç
FYFatima Yucel
Fatima Yucel
ABAynur Basalp
Aynur Basalp

14 December 2021 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
ABAylin Özdemi̇r Bahadir
Aylin Özdemi̇r Bahadir
BBBertan Koray Balcioğlu
Bertan Koray Balcioğlu
MSMüge Serhatli
Müge Serhatli
ŞIŞeyma Işik
Şeyma Işik
BEBerrin Erdağ
Berrin Erdağ
Gelatinases A and B, which are members of the matrix metalloproteinase (MMP) family, play essential roles in cancer development and metastasis, as they can break down basal membranes. Therefore, the determination and inhibition of gelatinases is essential for cancer treatment. Peptides that can specifically block each gelatinase may, therefore, be useful for cancer treatment. In this study, subtractive panning was carried out using a 12-mer peptide library to identify peptides that block gelatinase A activity (MMP-2), which is a key pharmacological target. Using this method, 17 unique peptide sequences were determined. MMP-2 inhibition by these peptides was evaluated through zymogram analyses, which revealed that four peptides inhibited MMP-2 activity by at least 65%. These four peptides were synthesized and used for in vitro wound healing using human umbilical vein endothelial cells, and two peptides, AOMP12 and AOMP29, were found to inhibit wound healing by 40%. These peptides are, thus, potential candidates for MMP2 inhibition for cancer treatment. Furthermore, our findings suggest that our substractive biopanning screening method is a suitable strategy for identifying peptides that selectively inhibit MMP-2.